project id: TCGA-LUAD; case submitter id: TCGA-95-7567; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 61; days to birth: -22437; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 22437; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 568.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; years smoked: 41.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-95-7567-01A-11; percent necrosis: 5.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 60.0;